Physician profile

John A Maslin

Nurse Practitioner · Tulsa, OK

NPI 1730797523

$1,518.07

in general payments reported to CMS, 2019-2025

16 companies · none reported in 2025

See the full distribution for Nurse Practitioner

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Fresenius USA Marketing, INC. $296.64 2021-2022
Astrazeneca Pharmaceuticals LP $271.93 2021
Mallinckrodt Hospital Products INC. $139.56 2021-2022
Ani Pharmaceuticals, INC. $127.35 2022
Daiichi Sankyo INC. $98.75 2021
Vifor Pharma, INC. $95.85 2021-2022
Novo Nordisk INC $94.76 2021-2022
Bayer Healthcare Pharmaceuticals INC. $82.59 2021-2022
Otsuka America Pharmaceutical, INC. $74.68 2021-2022
Amgen INC. $62.92 2021
Opko Pharmaceuticals, LLC $50.16 2021-2022
Akebia Therapeutics INC $39.27 2021-2022
Pharmacosmos Therapeutics INC. $26.19 2021
Alexion Pharmaceuticals, INC. $21.40 2021
Ultragenyx Pharmaceutical INC. $20.32 2021
Show all 16 companies
CompanyGeneral paymentsYearsTop products
Aurinia Pharma U.S., INC. $15.70 2021

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

John A Maslin

$1,518.07

in general payments reported 2019-2025

Years
2021-2022
Top company
Fresenius USA Marketing, INC.

https://glasscript.com/doctor/10593408/john-a-maslin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.